Queries the Open Targets Platform to identify therapeutic drug targets and analyze disease-target associations using human genetics and omics data.
This skill integrates the Open Targets Platform's vast dataset into Claude's workflow, enabling systematic identification and prioritization of potential drug targets. It provides programmatic access to the Open Targets GraphQL API, allowing users to evaluate target tractability, safety, and clinical precedence while gathering evidence from human genetics, pathways, and literature. It is an essential tool for computational biologists and pharmaceutical researchers performing target discovery, drug repurposing, or competitive intelligence.
Key Features
01Search disease-target associations with weighted evidence scores
02Evaluate target druggability and potential therapeutic liabilities
033,719 GitHub stars
04Retrieve drug information including clinical trial phases and mechanisms of action
05Access multi-source evidence from genetics, omics, and scientific literature
06Query target annotations for tractability, safety, and expression profiling
Use Cases
01Identifying existing drugs for repurposing through indication and mechanism analysis
02Evaluating the safety and tractability of a specific gene for drug development projects
03Prioritizing therapeutic targets for a specific disease based on human genetic evidence